JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walsh, S. L.
Right arrow Articles by Bigelow, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, S. L.
Right arrow Articles by Bigelow, G. E.

Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans

SL Walsh, JT Sullivan, KL Preston, JE Garner and GE Bigelow

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

This study evaluated the effects of i.v. cocaine, hydromorphone and their combination, and assessed the ability of oral naltrexone, an opioid antagonist, to modulate these effects. Volunteers with cocaine and heroin abuse histories (n = 8) participated in this placebo- controlled, cross-over study while residing on a closed research unit. Daily treatment with capsules containing placebo or naltrexone in ascending doses (3.125, 12.5, 50 and 200 mg) were given for 7-day periods. In thrice weekly experimental sessions, cocaine, hydromorphone and their combination were given in random order. Drug doses were given in an ascending order 1 hr apart as follows: cocaine at 0,20 and 40 mg, hydromorphone at 0, 1.5 and 3.0 mg, and the combination of 0 and 0 mg, 20 mg cocaine and 1.5 mg hydromorphone and 40 mg cocaine and 3.0 mg hydromorphone. Hydromorphone and cocaine produced distinct pharmacodynamic profiles, and the combination produced effects similar to both drugs. In some cases, the magnitude of effects produced by the combination was greater than that produced by either drug alone. Naltrexone produced dose-related blockade of hydromorphone effects, but did not after any of the physiological or subjective effects of cocaine. All naltrexone doses partially attenuated the effects of the combination and this appeared to be attributable to selective opioid blockade. These data do not support the use of naltrexone as a treatment for cocaine abuse, but suggest it may be useful for treating patients with concurrent cocaine and heroin abuse.

Volume 279, Issue 2, pp. 524-538, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. H. Ko, M. F. Divin, H. Lee, J. H. Woods, and J. R. Traynor
Differential in Vivo Potencies of Naltrexone and 6beta-Naltrexol in the Monkey
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 772 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. McMahon, S. L. Sell, and C. P. France
Cocaine and Other Indirect-Acting Monoamine Agonists Differentially Attenuate a Naltrexone Discriminative Stimulus in Morphine-Treated Rhesus Monkeys
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 111 - 119.
[Abstract] [Full Text] [PDF]


Home page
Behav Cogn Neurosci RevHome page
T. H. Kelly, W. W. Stoops, A. S. Perry, M. A. Prendergast, and C. R. Rush
Clinical Neuropharmacology of Drugs of Abuse: A Comparison of Drug-Discrimination and Subject-Report Measures
Behav Cogn Neurosci Rev, December 1, 2003; 2(4): 227 - 260.
[Abstract] [PDF]


Home page
Evid. Based Ment. HealthHome page
E. C Strain
Review: there is insufficient evidence for naltrexone maintenance treatment in opioid dependence
Evid. Based Ment. Health, May 1, 2003; 6(2): 57 - 57.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. M. Platt, D. M. Grech, J. K. Rowlett, and R. D. Spealman
Discriminative Stimulus Effects of Morphine in Squirrel Monkeys: Stimulants, Opioids, and Stimulant-Opioid Combinations
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1092 - 1100.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. K. Rowlett, K. M. Wilcox, and W. L. Woolverton
Self-Administration of Cocaine-Heroin Combinations by Rhesus Monkeys: Antagonism by Naltrexone
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 61 - 69.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. S. Negus, M. B. Gatch, and N. K. Mello
Discriminative Stimulus Effects of a Cocaine/Heroin "Speedball" Combination in Rhesus Monkeys
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1123 - 1136.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
N. K. Mello and S. S. Negus
The Effects of Buprenorphine on Self-administration of Cocaine and Heroin "Speedball" Combinations and Heroin Alone by Rhesus Monkeys
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 444 - 456.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.